Medicare
Unclassified, FDA-approved drugs administered to outpatients will be reimbursed
Published in Drug Week, June 25th, 2004
In an effort to ensure that Medicare beneficiaries have prompt access to the latest drugs used in conjunction with a covered hospital outpatient service, the U.S. Centers for Medicare & Medicaid Services (CMS) has issued instructions telling the contractors that process claims under the hospital outpatient prospective payment system (OPPS) how to pay for new drugs that have been approved by the U.S. Food and Drug Administration, but have not yet been assigned a product-specific HCPCS billing code.
The instructions, which implement a provision of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), authorize payment for drugs and biologicals...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-06-25)
More Articles from Drug Week
- Asthma
Clinical trial to evaluate Xolair in pediatric allergic asthma patients - Breast Cancer
Chemotherapy including epirubicin may improve survival for some patients - Non-Hodgkin Lymphoma
FDA accepts Onco TCS new drug application - Pneumonia
FDA approves Avelox (moxifloxacin HCI) for community-acquired pneumonia - AIDS Vaccine
Volunteers needed as more AIDS vaccines move into clinical trials - Adverse Drug Effects
Lupus-like syndrome linked to simvastin therapy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
